Literature DB >> 29427501

Infections complicating cirrhosis.

Salvatore Piano1, Alessandra Brocca1, Sara Mareso1, Paolo Angeli1.   

Abstract

Patients with cirrhosis have a high risk of bacterial infections. Bacterial infections induce systemic inflammation that may lead to organ failure and acute-on-chronic liver failure (ACLF) resulting in a high risk of short term mortality. The early diagnosis and treatment of bacterial infections is essential to improve the patient's prognosis. However, in recent years, the spread of multidrug resistant (MDR) bacterial infections has reduced the efficacy of commonly used antibiotics such as third generation cephalosporins. In patients at high risk of MDR bacteria, such as those with nosocomial infections, the early administration of broad spectrum antibiotics has been shown to improve the prognosis. However, early de-escalation of antibiotics is recommended to reduce a further increase in antibiotic resistance. Strategies to prevent acute kidney injury and other organ failures should be implemented. Although prophylaxis of bacterial infections with antibiotics improves the prognosis in selected patients, their use should be limited to patients at high risk of developing infections. In this article, we review the pathogenesis and management of bacterial infections in patients with cirrhosis.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acute-on-chronic liver failure; antibiotics; liver cirrhosis; sepsis; spontaneous bacterial peritonitis

Mesh:

Substances:

Year:  2018        PMID: 29427501     DOI: 10.1111/liv.13645

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  33 in total

1.  Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.

Authors:  Jasmohan S Bajaj; Jacqueline G OʼLeary; Puneeta Tandon; Florence Wong; Guadalupe Garcia-Tsao; Patrick S Kamath; Scott W Biggins; Jennifer C Lai; Hugo E Vargas; Benedict Maliakkal; Michael B Fallon; Paul J Thuluvath; Ram M Subramanian; Leroy R Thacker; K Rajender Reddy
Journal:  Am J Gastroenterol       Date:  2019-07       Impact factor: 10.864

Review 2.  Clinical Consequences of Infection in Cirrhosis: Organ Failures and Acute-on-Chronic Liver Failure.

Authors:  Florence Wong
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

Review 3.  Current Concepts on Bacterial and Fungal Infections in Cirrhosis.

Authors:  Salvatore Piano; Paolo Angeli
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

Review 4.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

Authors:  Andrew M Moon; Amit G Singal; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-08       Impact factor: 11.382

5.  Alterations in Skin Microbiomes of Patients With Cirrhosis.

Authors:  Jasmohan S Bajaj; Andrew Fagan; Masoumeh Sikaroodi; Genta Kakiyama; Hajme Takei; Yordanos Degefu; William M Pandak; Phillip B Hylemon; Michael Fuchs; Binu John; Douglas M Heuman; Edith Gavis; Hiroshi Nittono; Rohan Patil; Patrick M Gillevet
Journal:  Clin Gastroenterol Hepatol       Date:  2019-03-21       Impact factor: 11.382

6.  Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: A population-based study.

Authors:  Isanka U Ratnasekera; Amy Johnson; Elizabeth E Powell; Andrew Henderson; Katharine M Irvine; Patricia C Valery
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

7.  Prevalence, Predictors, and Outcomes of Esophageal Candidiasis in Cirrhosis: An Observational Study With Systematic Review and Meta-Analysis (CANDID-VIEW).

Authors:  Nipun Verma; Saurabh Mishra; Shreya Singh; Arka De; Madhumita Premkumar; Sunil Taneja; Ajay Duseja; Virendra Singh
Journal:  J Clin Exp Hepatol       Date:  2021-03-21

8.  Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.

Authors:  Runping Liu; Jason D Kang; R Balfour Sartor; Masoumeh Sikaroodi; Andrew Fagan; Edith A Gavis; Huiping Zhou; Phillip B Hylemon; Jeremy W Herzog; Xiaojiaoyang Li; Robert H Lippman; Javier Gonzalez-Maeso; James B Wade; Siddhartha Ghosh; Emily Gurley; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.298

Review 9.  The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure.

Authors:  Evangelos Triantafyllou; Kevin J Woollard; Mark J W McPhail; Charalambos G Antoniades; Lucia A Possamai
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

Review 10.  Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies.

Authors:  Sebastián Marciano; Juan Manuel Díaz; Melisa Dirchwolf; Adrián Gadano
Journal:  Hepat Med       Date:  2019-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.